Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust with big names in an emerging heart disease drug arena. Backed by ...

Board to include Chris Viehbacher as Chair, with investor syndicate led by Andreessen Horowitz, Forbion, and OrbiMed with participation from Enavate Sciences (a platform of Patient Square Capital) and ...

Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s one of the largest ...

Chris Hemsworth, Alzheimer's and why Hollywood is suddenly obsessed with caregiving Why Trump is holding back on helping people who can't buy food Cleaning woman shot and killed after arriving at ...

Every movie has its share of mistakes, but some are so good they end up staying in the final version. This video counts down ten famous bloopers and unscripted moments that directors and editors ...

And of course, everything has come full circle and next week, The Answer will be celebrating Zeppelin’s iconic 1971 Ulster ...

They’re sharp, original and delivered with the kind of disarming charm that makes you wonder why Hollywood hasn’t already followed her lead. “Don’t you think there should be a blooper button on ...

Team Reporter Casey Phillips sits down with Buccaneers Pass Game Coordinator George Edwards following the Week 13 matchup against the Arizona Cardinals. They discuss managing situational football, the ...